Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

NCT01843387 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Mesoblast, Ltd.